In univariate Cox analyses (Table 2), hemoglobin ≥10 g% (p = 0.02), serum albumin ≥3 g% (p = 0.04), CD4 lymphocyte count ≥100 cells/mm3 (p = 0.04) and HAART use during TB treatment (p = 0.01) were associated with a significant lower risk of early mortality. The gene discussed is ALB; the disease is tuberculosis.